Known commercially under names such as Wegovy, designed expressly for weight management, and Ozempic, intended for type 2 diabetes treatment, semaglutide recently expanded its options with the FDA approving the Wegovy pill for those preferring oral medication over injections
The procedure is non-invasive, painless, and time-efficient
Yes the most-cited one is a 2007 study in Archives of Pharmacal Research showing that a copper tripeptide stimulated human hair-follicle elongation ex vivo and dermal papilla cell proliferation in vitro
However, based also on small histopathologic studies that pointed to a marked expansion of the exocrine and endocrine pancreatic compartments with the use of incretin-based therapies, the former being accompanied by increased proliferation and dysplasia and the latter by -cell hyperplasia with the potential for evolution into neuroendocrine tumors [105], concerns remain [106], and monitoring for and reporting of pancreatic adverse effects will continue [104]
These side effect do not require medical attention and gradually resolve over time
The STEP 1 clinical trial, published in the New England Journal of Medicine , found that once-weekly semaglutide produced an average body weight reduction of 14.9% over 68 weeks